Aaron Scholnik, M.D., P.K. Pathak, Ph.D., Principal Investigators John McPhail, (Project Manager), Renu Pandit, M.D., Asif Masood, M.D., Department of.

Slides:



Advertisements
Similar presentations
Commission on Cancer Mission
Advertisements

Geraldine O’Dowd Consultant Pathologist NHS Lanarkshire 18 th November 2014 Colorectal Cancer Pathology: Impact of new guidelines for the laboratory.
TNM staging and prognosis Alexandru Eniu, MD, PhD Medical Oncologist Department of Breast Tumors Cancer Institute Ion Chiricuţă Cluj-Napoca, Romania.
Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.
STAGING MCR Staff Show Me Healthy Women March 27, 2008 Supported by a Cooperative Agreement between DHSS and the Centers for Disease Control and Prevention.
Polyps – Where do they come from and what do you do with them?!
AJCC TNM Staging 7th Edition Thyroid Case #3
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
AJCC Staging Moments AJCC TNM Staging 7th Edition Glottic Larynx Case #1 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New York,
THE DEVELOPMENT OF SYNOPTIC REPORTS FROM FREE TEXT CONTENT OF ARCHIVAL PATHOLOGY REPORTS GENERATED IN THE ANATOMIC PATHOLOGY LABORATORY INFORMATION SYSTEM.
Sandy Jones Public Health Advisor CDC Cancer Surveillance Branch July 23, 2014 STANDARDIZATION FOR REPORTING CANCER BIOMARKER TEST DATA National Center.
Grade 1 (almost) never assigned Grade 2 rarely assigned on TURP and RP (exceptionally rare on biopsy)
Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance Professor, Medical Oncology, University of Washington School of Medicine.
Cancer Staging. What is cancer staging? Staging describes the severity of a person’s cancer based on the extent of the original (primary) tumor and whether.
AJCC TNM Staging 7th Edition Breast Case #3
Prostate Needle Biopsy: The Pitfalls and the Role of the Pathologist – Patient Track Prostate Cancer Symposium “Intriguing Cases / Emerging Strategies.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Eleni Galani Medical Oncologist
How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
1 MP/H Coding Rules General Instructions MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Cancer Staging.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
Principles of Surgical Oncology Salah R. Elfaqih.
Principles of Surgical Oncology Salah R. Elfaqih.
1 CAP Audio Conference on the CMS 2009 Physician Quality Reporting Initiative Jonathan Myles, MD, FCAP College of American Pathologists December 17, 2008.
2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Quality in Cancer Surgery Dr. Craig McFadyen VP Cancer Services, Grand River Hospital Regional VP (Waterloo-Wellington), Cancer Care Ontario Medical Director.
Organization and guideline development April 2010 ACCC The Netherlands.
First author: Roman Adina Co-author: Andone Sebastian
1000 Lives Annual Report North of England Cancer Network Annual Conference 20 th September 2013.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
MBCG Project Primary Results MEDICALSURVEYS-17 RESEARCH GROUP IN COLLABORATION WITH THE EASO.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.
Pathology.
Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.
From Qualitative to Quality Impact Heather Bryant, MD, PhD Health System Use Summit February, 2016.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
Kyung Hee University, Seoul, Korea Conference LGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Electronic CAP Cancer Checklists and Cancer Registries – A Pilot Project 2009 NAACCR Conference Ken Gerlach, MPH, CTR Castine Verrill, MS, CTR CDC-National.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
NPCR Data Completeness and Quality Audits Review of: Collaborative Stage and Surgery Data Mary Lewis, CTR NPCR Program Consultant.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
SNOMED CT and Surgical Pathology
THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE
SNOMED CT® in Surgical Pathology and Cancer Registry Work
Underwriting Breast Cancer
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Standardization of Electronic Templates for Cancer and Biomarker Reporting Keren I. Hulkower, PhD I’m a Quality Control Informaticist within the Structured.
SNOMED CT and Surgical Pathology
Principles of Surgical Oncology
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
What’s New for 8th Edition
College of American Pathologists
Treatment Overview: The Multidisciplinary Team
흉부영상집답회 case review 강동경희대병원 이한나.
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
Changes in TNM 8 To be used from
NSCLC: Staging and TNM classification
Presentation transcript:

Aaron Scholnik, M.D., P.K. Pathak, Ph.D., Principal Investigators John McPhail, (Project Manager), Renu Pandit, M.D., Asif Masood, M.D., Department of Epidemiology Michigan State University East Lansing, MI Michigan Basic Pathology Lexicon Project and Reporting Formats for Cancer

Vision Develop a format which: Is scientifically validated, clinically useable, and user friendly Is a common format for hospitals across Michigan Concept to be extended to other anatomical sites and pathology specimens (biopsies, excisions)

Early 2005 Priority Objective Goal for Standardized (Basic) Lexicon: (Pages 4-5) By 2006, develop and disseminate basic pathology protocols and reporting formats for examination of cancerous tissue specimens and determine the need for similar surgical pathology reporting formats that include data important in making breast and prostate (including core biopsies), cervical, colorectal (including polypectomies that contain cancer), and lung cancer treatment and prognostic decisions. *Note: This will now include breast and prostate needle biopsies, colorectal polypectomies, and other endoscopic biopsies.

Updated Priority Objective Goal: “By 2006, finalize, disseminate, and evaluate basic pathology lexicons for breast, prostate, and colorectal, cervix and lung cancers to include information for making prognostic and treatment decisions. Further expand the number of pathology lexicons to include all common cancer types to enhance their adoption as a reporting system.”

Pathology LEXICON Is a collaborative effort of MDCH, MSU, and other institutions to generate a consensus format for the reporting of breast, colorectal, and prostate cancers.

Cooperating Organizations Michigan Department of Community Health Michigan Society of Tumor Registrars (page 16) Michigan Society of Pathologists (pages 17-19) American College of Surgeons Michigan Public Health Institute – Cancer Control Services Project Michigan Society of Hematology and Oncology

A “Call to Action” Implications for MCC Member Organizations over the next 2 years: FOCUS- Lab Facilities/Health Care Systems Educate health care professionals regarding the methodology and benefit of incorporating a basic lexicon to improve cancer diagnosis and treatment. Encourage participation in the pilot/evaluation phase of the draft template of the basic lexicon within your facility/organization. Support use of the finalized product (template) within all MI facilities/organizations.

ACOS-CoC Guidelines for Cancer Reporting (Page 6) The Cancer Program Standards 2004 publication specifies that the CoC requires 90 percent of pathology reports which include a cancer diagnosis will contain the scientifically validated data elements outlined on the surgical case summary checklist of the College of American Pathologists (CAP) publication, Reporting on Cancer Specimens.

ACOS-CoC Guidelines for Cancer Reporting 1) A specific style of report is not required. Both synoptic or narrative reporting are acceptable, however, synoptic reporting is preferred. 2) There is no set order in which the elements must appear.

ACOS-CoC Guidelines for Cancer Reporting 3) No specific location for the scientifically validated elements within the pathology report has been set. For example, the scientifically validated data elements may be reported in either the Macroscopic [gross] description, the Microscopic description, the Pathologic Diagnosis, or the Special Studies section of the report.

Steering Committee and Expert Panel Please see pages 7, 8, 9, and 10

LEXICON in the Making Gathered data from 52 facilities across MI, which report at least 250 cases/year Hospitals were requested to submit their formats/ checklists to identify their cancer reporting practices Each institution was expected to submit only one format for each cancer site, independent of the # of pathologists/institution No actual pathology reports were required

Pathology LEXICON Template (pages 12-15) _____ COLON RESECTION SPECIMEN : _____________________ 6 TH ADDITION AJCC STAGING: pT__ pN__ pM__ HISTOLOGY Histologic Type: _______ Histologic Grade: _______ Deepest bowel layer invasion: _______ MARGINS (yes,no) Proximal and distal:_______ for tumor cm from tumor to margin: _______ Radial:_______ cm from tumor to margin: _______ for tumor VISCERAL PERITONEUM: ______ for tumor VASCULAR / LYMPHATIC STATUS (yes,no) Large vessel: _______ for tumor Small vessel: _______ for tumor Lymphatics: _______ for tumor LYMPH NODES: ______ of _____ nodes contain tumor ADDITIONAL PATHOLOGY: ______ COMMENTS: ______

____ PROSTECTOMY SPECIMEN: ADENOCARCINOMA AJCC 6 TH EDITION STAGING: pT __ pN__ pM __ HISTOLOGIC PATTERN / SCORE Primary: _____ of 5 Secondary: _____ of 5 Tertiary: _____ of 5 Total Gleason Score: _____ of 10 EXTENT OF SPREAD *Right gland replaced: _____ % *Left gland replaced: _____ % Portion of total gland replaced: _____ % Margins of excision: _____ If present, location(s): _____ Involvement of apex margins: _____ Extracapsular extension:_____ If present, location(s): _____ Seminal Vesicle Invasion: _____ If present, location(s): _____ Other pelvic tissue: _____ If present, location(s): _____ *Perineural: _____ *Venous: _____

__________ BREAST SPECIMEN:__________ carcinoma AJCC 6 TH EDITION PATHOLOGIC STAGING: pT__ pN__ pM__ HISTOLOGY, INVASIVE Nottingham grade (specify if other): _______ of 3 Greatest dimension: _______ cm HISTOLOGY, IN SITU Type: _______ Grade: _______ of 3 Extent (> or < than 25% of mass): _______ PROGNOSTIC MARKERS / RECEPTORS Estrogen : _______ Progesterone: _______ Her2-neu: _______ LOCAL EXTENT OF SPREAD Lymph nodes, Macro-metastasis ( > 2.0 mm): ___ of ___ nodes positive for tumor Lymph nodes, Micro-metastasis (> 0.2 but < 2.0 mm): ___ of ___ nodes positive for tumor Lymph nodes, Isolated tumor cells/clusters (< 0.2 mm): ___ of ___ nodes positive for tumor Margin analysis Invasive carcinoma: _______ for invasive carcinoma If positive extent: _______ If neg., cm to margin: ___ cm. In situ carcinoma: _______ for in situ carcinoma If positive, extent: _______ If neg., cm to margin: ___ cm. Lymphatic invasion: _______ Vascular invasion: _______ Microcalcifications: _______ Skin ulceration: _______ Satellite skin nodules: _______ OTHER: _______

LEXICON on the Road Lexicon was presented at: MCC Annual Meeting 2003 and received “Spirit of Collaboration” award MICRA Annual Meeting, Sept MSP Meeting, 2004 MCC Priority Review, June 16, 2004

Collaborative Efforts Identified similar projects in Ohio and California Held teleconferences and learned from their experiences

Piloting LEXICON Lexicon has been tried at participating institutions: Ingham Regional Medical Center, Marquette General Hospital, and Wayne State/Karmanos Cancer Institute

Evaluation Instrument An evaluation instrument has been developed (please see page 20) This could be completed on paper or on the web

LEXICON – An Evolving Concept LEXICON is all about sharing knowledge and developing grounds for mutual understanding and agreement. We are looking forward to learning from you, your thoughts, and your feedback.

LEXICON Agreement (Page 30) Templates designed so far are in a DRAFT form only. Please disseminate only once they are finalized.

A Review of the Priorities and Recommendation to MCC Board Early 2005 Priority Updated Priority Objective Goal By 2005, develop and disseminate basic pathology protocols and reporting formats for examination of cancer tissue specimens and determine the need for similar surgical reporting formats that include data important in making breast, cervical, colorectal, lung, and prostate cancer treatment and prognostic decisions. *Note: This will now include breast and prostate needle biopsies, colorectal polypectomies, and other endoscopic biopsies. “By 2006, finalize, disseminate, and evaluate basic pathology lexicons for breast, prostate, and colorectal, cervix and lung cancers to include information for making prognostic and treatment decisions. Further expand the number of pathology lexicons to include all common cancer types to enhance their adoption as a reporting system.”

Recommendation from the Board (continued…) Change the name of the project from: The Michigan Common (or Standardized) Pathology Lexicon Project to: The Michigan Basic Pathology Lexicon Project